How missing evidence-based medicine indicators can inform COVID-19 vaccine distribution policies: a scoping review and calculation of indicators from data in randomised controlled trials.

Andrew Larkin Howard Waitzkin Ella Fassler Kesavan Rajasekharan Nayar

Published in: BMJ open (2022)

Priorities for vaccine distribution should target subpopulations with higher baseline risks. Similar analyses using ARR/NNV and ARI/NNH would strengthen evaluations of vaccines' benefits versus harms. An EBM perspective on vaccine distribution that emphasises baseline risks becomes especially important as the world's population continues to face major barriers to vaccine access-sometimes termed 'vaccine apartheid'.

Keyphrases

coronavirus disease
sars cov
public health
machine learning
electronic health record
big data
artificial intelligence